These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 22851570

  • 1. Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.
    Castle PE, Glass AG, Rush BB, Scott DR, Wentzensen N, Gage JC, Buckland J, Rydzak G, Lorincz AT, Wacholder S.
    J Clin Oncol; 2012 Sep 01; 30(25):3044-50. PubMed ID: 22851570
    [Abstract] [Full Text] [Related]

  • 2. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE, Stoler MH, Wright TC, Sharma A, Wright TL, Behrens CM.
    Lancet Oncol; 2011 Sep 01; 12(9):880-90. PubMed ID: 21865084
    [Abstract] [Full Text] [Related]

  • 3. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
    Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M.
    J Natl Cancer Inst; 2005 Jul 20; 97(14):1072-9. PubMed ID: 16030305
    [Abstract] [Full Text] [Related]

  • 4. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.
    Guo M, Gong Y, Wang J, Dawlett M, Patel S, Liu P, Bevers TB, Sneige N.
    Cancer Cytopathol; 2013 Feb 20; 121(2):79-85. PubMed ID: 23225501
    [Abstract] [Full Text] [Related]

  • 5. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3.
    Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE.
    Cancer Epidemiol Biomarkers Prev; 2010 Jul 20; 19(7):1675-81. PubMed ID: 20615885
    [Abstract] [Full Text] [Related]

  • 6. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    Dijkstra MG, van Zummeren M, Rozendaal L, van Kemenade FJ, Helmerhorst TJ, Snijders PJ, Meijer CJ, Berkhof J.
    BMJ; 2016 Oct 04; 355():i4924. PubMed ID: 27702796
    [Abstract] [Full Text] [Related]

  • 7. Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance.
    Wong AK, Chan RC, Nichols WS, Bose S.
    Cancer; 2009 Feb 15; 115(4):823-32. PubMed ID: 19127558
    [Abstract] [Full Text] [Related]

  • 8. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK, Frederiksen K, Munk C, Iftner T.
    J Natl Cancer Inst; 2010 Oct 06; 102(19):1478-88. PubMed ID: 20841605
    [Abstract] [Full Text] [Related]

  • 9. Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study.
    Gori S, Battagello J, Gustinucci D, Campari C, Zorzi M, Frayle H, Passamonti B, Sartori G, Bulletti S, Fodero C, Cesarini E, Faggiano R, Del Mistro A.
    BJOG; 2021 Jul 06; 128(8):1353-1362. PubMed ID: 33326680
    [Abstract] [Full Text] [Related]

  • 10. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.
    Castle PE, Shaber R, LaMere BJ, Kinney W, Fetterma B, Poitras N, Lorey T, Schiffman M, Dunne A, Ostolaza JM, McKinney S, Burk RD.
    Cancer Epidemiol Biomarkers Prev; 2011 May 06; 20(5):946-53. PubMed ID: 21415357
    [Abstract] [Full Text] [Related]

  • 11. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18.
    Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL, Ho J, Kiviat NB.
    Cancer Epidemiol Biomarkers Prev; 2007 Jan 06; 16(1):4-10. PubMed ID: 17220325
    [Abstract] [Full Text] [Related]

  • 12. The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management.
    Gage JC, Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Behrens C, Sharma A, Zhao FH, Cuzick J, Yang ZH, Kinney WK.
    Cancer Cytopathol; 2014 Nov 06; 122(11):842-50. PubMed ID: 25045058
    [Abstract] [Full Text] [Related]

  • 13. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M.
    J Natl Cancer Inst; 2003 Jan 01; 95(1):46-52. PubMed ID: 12509400
    [Abstract] [Full Text] [Related]

  • 14. Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.
    Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LC, Cuzick J, Myers O, Castle PE, Wheeler CM, New Mexico HPV Pap Registry Steering Committee.
    Cancer Epidemiol Biomarkers Prev; 2016 Jan 01; 25(1):36-42. PubMed ID: 26518316
    [Abstract] [Full Text] [Related]

  • 15. Assessment of HPV DNA test value in management women with cytological findings of ASC-US, CIN1 and CIN2.
    Pajtler M, Milicić-Juhas V, Milojković M, Topolovec Z, Curzik D, Mihaljević I.
    Coll Antropol; 2010 Mar 01; 34(1):81-6. PubMed ID: 20432737
    [Abstract] [Full Text] [Related]

  • 16. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J, Cortiñas P, Loureiro CL, Pujol FH, Medina F, Capote-Negrín L, Bianchi G, García-Barriola V, Ruiz-Benni A, Avilán-Rovira J, Acosta H.
    Cancer Epidemiol; 2012 Oct 01; 36(5):e284-7. PubMed ID: 22608058
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevalence of HPV-16/18 genotypes and immediate histopathologic correlation results in a Chinese population with negative cytology and positive high-risk HPV testing.
    Tao X, Zhang H, Li J, Zhang H, Xiao J, Zhang L, Zhou X, Sui L, Wang L, Zhao C.
    Cancer Cytopathol; 2019 Oct 01; 127(10):650-657. PubMed ID: 31532582
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.